Blood lead levels and mortality

Archives of Internal Medicine

Volumn 162, Issue 21, 2002, Pages 2443-2449

  Lustberg, Mark ^a   Silbergeld, Ellen ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b The Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ADULT; AGED; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; FEMALE; HEALTH SURVEY; HUMAN; LEAD BLOOD LEVEL; MALE; MORTALITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGED; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEAD; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS; RISK; UNITED STATES; VASCULAR DISEASES;

EID: 0037175508     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.21.2443     Document Type: Article

References (43)

1. Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States: The National Health and Nutrition Examination Surveys (NHANES). JAMA. 1994;272:284-291.
2. Rice DC. Behavioral effects of lead: Commonalities between experimental and epidemiologic data. Environ Health Perspect. 1996;104:337-351.
3. Kopp SJ, Barron JT, Tow JP. Cardiovascular actions of lead and relationship to hypertension: A review. Environ Health Perspect. 1988;78:91-99.
4. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect. 1997;105:928-939.
5. Silbergeld EK, Waalkes M, Rice JM. Lead as a carcinogen: Experimental evidence and mechanisms of action. Am J Ind Med. 2000;38:316-323.
6. Landrigan PJ, Boffetta P, Apostoli P. The reproductive toxicity and carcino-genicity of lead: A critical review. Am J Ind Med. 2000;38:231-243.
7. Feldman RG, White RF. Lead neurotoxicity and disorders of learning. J Child Neurol. 1992;7:354-359.
8. Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev. 1993;15:352-373.
9. Onalaja AO, Claudio L. Genetic susceptibility to lead poisoning. Environ Health Perspect. 2000;108:23-28.
10. Mahaffey K. Environmental lead toxicity: Nutrition as a component of intervention. Environ Health Perspect. 1990;89:75-80.
11. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med. 2000;20:927-945.
12. Lundstrom NG, Nordberg G, Englyst V, et al. Cumulative lead exposure in relation to mortality and lung cancer mortality in a cohort of primary smelter workers. Scand J Work Environ Health. 1997;23:24-30.
13. Cocco P, Hua F, Boffetta P, et al. Mortality of Italian lead smelter workers. Scand J Work Environ Health. 1997;23:15-23.
14. Anttila A, Heikkila P, Pukkala E, et al. Excess lung cancer among workers exposed to lead. Scand J Work Environ Health. 1995;21:460-469.
15. Cooper WC, Wong O, Kheifets L. Mortality among employees of lead battery plants and lead-producing plants, 1947-1980. Scand J Work Environ Health. 1985;11: 331-345.
16. Michaels O, Zoloth SR, Stern FB. Does low level lead exposure increase risk of death? A mortality study of newspaper printers. Int J Epidemiol. 1991;20:978-983.
17. Steenland K, Selevan S, Landrigan P. The mortality of lead smelter workers: An update. Am J Public Health. 1992;82:1641-1644.
18. Gerhardsson L, Lundstrom NG, Nordberg G, Wall S. Mortality and lead exposure: A retrospective cohort study of Swedish smelter workers. Br J Ind Med. 1986;43:707-712.
19. Wong O, Harris F. Cancer mortality study of employees at lead battery plants and smelters, 1947-1995. Am J Ind Med. 2000;38:255-270.
20. Gerhardsson L, Hagmar L, Rylander L, Skerfving S. Mortality and cancer incidence among secondary lead smelter workers. Occup Environ Med. 1995;52: 667-672.
21. McDonald JA, Potter NU. Lead's legacy? Early and late mortality of 454 lead-poisoned children. Arch Environ Health. 1996;51:116-121.
22. Moller L, Kristensen T. Blood lead as a cardiovascular risk factor. Am J Epidemiol. 1992;136:1091-1100.
23. McDowell A, Engle A, Massey J, Maurer K. Plan and operation of the Second National Health and Nutrition Survey, 1976-1980. Vital Health Stat 1. 1981;No. 15:1-144.
24. Loria C, Sempos C, Vuong C. Plan and operation of the NHANES II Mortality Study, 1992. Vital Health Stat 1. 1999; No. 38:1-16.
25. Gunter EW, Turner WE, Neese JW, Bayse DB. Laboratory Procedures Used by the Clinical Chemistry Division, Centers for Disease Control, for the Second National Health and Nutrition Examination Survey (NHANES II), 1976-1980. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control, Center for Environmental Health, Nutritional Biochemistry Branch; 1982.
26. Brody D, Pirkle J, Kramer R, et al. Blood lead levels in the US population: Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA. 1994;272:277-283.
27. Baillargeon J. Characteristics of the healthy worker effect. Occup Med. 2001;16: 359-366.
28. Malcolm D, Barnett HA. A mortality study of lead workers, 1925-1976. Br J Ind Med. 1982;39:404-410.
29. Dingwall-Fordyce I, Lane R. A follow-up study of lead workers. Br J Ind Med. 1963;20:313-315.
30. Chai SS, Webb RC. Effects of lead on vascular reactivity. Environ Health Perspect 1988;78:85-89.
31. Markovac J, Goldstein GW. Picomolar concentrations of lead stimulate brain protein kinase C. Nature. 1988;334:71-73.
32. Perry HM, Erlanger MW, Perry EF. Increase in the blood pressure of rats chronically fed low levels of lead. Environ Health Perspect. 1988;78:107-111.
33. Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health. 1995;50:31-37.
34. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: The Normative Aging Study. Am J Epidemiol. 2001;153: 164-171.
35. Zawia NH, Crumpton T, Brydie M, Reddy GR, Razmiafshari M. Disruption of the zinc finger domain: A common target that underlies many of the effects of lead. Neurotoxicology. 2000;21:1069-1080.
36. Hunaiti AA, Soud M. Effect of lead concentration on the level of glutathione, glutathione S-transferase, reductase, and peroxidase in human blood. Sci Total Environ. 2000;248:45-50.
37. Hartwig A. Role of DNA repair inhibition in lead and cadmium induced genotoxicity: A review. Environ Health Perspect. 1994;102:45-50.
38. Quintanilla-Vega B, Hoover D, Bal W, Silbergeld EK, Waalkes MP, Anderson LD. Lead effects on protamine-DNA binding. Am J Ind Med. 2000;38:324-329.
39. Roy N, Rossman T. Mutagenesis and comutagenesis by lead compounds. Mutat Res. 1992;298:97-103.
40. Hartwig A, Schlepegrell R, Beyersmann D. Indirect mechanism of lead-induced genotoxicity in cultured mammalian cells. Mutat Res. 1990;241:75-82.
41. Occupational Safety and Health Administration. Occupational exposure to lead. 43 Federal Register 54353-54616 (1978).
42. US Department of Health and Human Services (DHHS), National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Laboratory Data File [CD-ROM]. Hyattsville, Md: Centers for Disease Control and Prevention; 1996. Public use data file documentation 76200.
43. Adult blood lead epidemiology and surveillance: United States, second and third quarters, 1998, and annual 1994-1997. MMWR Morb Mortal Wkly Rep. 1999;48:213-216, 223.